Physician profile
Michelle Ned
NPI 1528785623
$679.31
in general payments reported to CMS, 2019-2025
16 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $43.16 · 2024: $329 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $115.42 | 2025 | |
| Genzyme Corporation | $110.07 | 2024 | |
| Pfizer INC. | $104.36 | 2024-2025 | |
| Corium, LLC | $51.45 | 2025 | Azstarys |
| Abbvie INC. | $42.24 | 2025 | |
| Lilly USA, LLC | $37.82 | 2025 | Mounjaro, Zepbound |
| Supernus Pharmaceuticals, INC. | $37.26 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $36.31 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $31.12 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Novo Nordisk INC | $20.21 | 2025 | |
| Sanofi-Aventis U.S. LLC | $19.63 | 2024 | |
| Cranial Technologies, INC | $17.51 | 2024 | Doc Band |
| Exact Sciences Corporation | $14.46 | 2025 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $14.33 | 2024 | |
| Nestle Healthcare Nutrition INC. | $13.92 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $13.20 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ned listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.